Who Paid My Doc
Miguel Gonzalez
Clinical Nurse Specialist Fort Myers, FL Nurse Practitioner
NPI 1962928994 CMS profile 11029765
13880 Shell Point Plaza, Suite 110, Fort Myers, FL 33908
General payments
$381
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Miguel Gonzalez of Fort Myers, FL is reported in the CMS Open Payments database as having received $381 across 13 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 56th percentile of Clinical Nurse Specialist profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $321 | 10 | |
| 2024 | General | $23 | 1 | |
| 2023 | General | $24 | 1 | |
| 2022 | General | $13 | 1 |
Beside peers
- Miguel Gonzalez
- Clinical Nurse Specialist median
- Middle half of Clinical Nurse Specialist
- National median
In program year 2025, general payments to Miguel Gonzalez were reported at $321. Among 490 Clinical Nurse Specialist profiles paid that year, the median was $149 and the middle half received between $61 and $470.
Show as a table
| Year | Miguel Gonzalez | Clinical Nurse Specialist median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $132 | $42–$386 | $132 |
| 2022 | $13 | $140 | $55–$364 | $149 |
| 2023 | $24 | $145 | $50–$403 | $160 |
| 2024 | $23 | $145 | $55–$430 | $164 |
| 2025 | $321 | $149 | $61–$470 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 45 drugsPart D claims
1,951
Drug cost
$38,045
Branded share of claims
7.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 60 | $17,641 | |
| Sps Sodium Polystyrene Sulfon/Sorb | Brand | 14 | $3,627 | |
| Levothyroxine Sodium | Generic | 226 | $1,908 | |
| Mirtazapine | Generic | 73 | $1,071 | |
| Metoprolol Succinate | Generic | 86 | $1,048 | |
| Warfarin Sodium | Generic | 145 | $900 | |
| Atorvastatin Calcium | Generic | 112 | $750 | |
| Gabapentin | Generic | 68 | $653 | |
| Fluticasone Propionate | Generic | 36 | $652 | |
| Amlodipine Besylate | Generic | 91 | $635 |
The 10 drugs with the highest cost, of 45 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 41 billing codesPaid by Medicare
$167,645
Medicare patients
784
Services billed
3,055
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 72% | |
| Ischemic heart disease | 40% | |
| Atrial fibrillation | 37% | |
| Chronic kidney disease | 35% | |
| Depression | 30% | |
| Osteoporosis | 30% | |
| Alzheimer's or dementia | 26% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, denosumab, 1 mg J0897 | Office | 13 | 840 | $16,022 |
| Vaccine for influenza for injection into muscle 90662 | Office | 83 | 83 | $6,791 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
13 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Nurse Specialist in Florida
Robin Gasparini
Clinical Nurse Specialist · Fernandina Beach, FL
Patricia Geddie
Clinical Nurse Specialist · Orlando, FL
Tammy McCarty
Clinical Nurse Specialist · Fort Myers, FL
Clarissa Welbaum
Clinical Nurse Specialist · Orlando, FL
Roberta Marino
Clinical Nurse Specialist · Fort Myers, FL
Allison Tuppeny
Clinical Nurse Specialist · Orlando, FL
Related records
Clinical Nurse Specialist in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Nurse Specialist
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.